These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10681555)

  • 1. A role for a helical connector between two receptor binding sites of a long-chain peptide hormone.
    Beyermann M; Rothemund S; Heinrich N; Fechner K; Furkert J; Dathe M; Winter R; Krause E; Bienert M
    J Biol Chem; 2000 Feb; 275(8):5702-9. PubMed ID: 10681555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constrained corticotropin-releasing factor (CRF) agonists and antagonists with i-(i+3) Glu-Xaa-DXbb-Lys bridges.
    Koerber SC; Gulyas J; Lahrichi SL; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1998 Dec; 41(25):5002-11. PubMed ID: 9836618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.
    Klose J; Fechner K; Beyermann M; Krause E; Wendt N; Bienert M; Rudolph R; Rothemund S
    Biochemistry; 2005 Feb; 44(5):1614-23. PubMed ID: 15683245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally restricted competitive antagonists of human/rat corticotropin-releasing factor.
    Miranda A; Koerber SC; Gulyas J; Lahrichi SL; Craig AG; Corrigan A; Hagler A; Rivier C; Vale W; Rivier J
    J Med Chem; 1994 May; 37(10):1450-9. PubMed ID: 8182703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor (CRF) agonists stimulate testosterone production in mouse leydig cells through CRF receptor-1.
    Heinrich N; Meyer MR; Furkert J; Sasse A; Beyermann M; Bönigk W; Berger H
    Endocrinology; 1998 Feb; 139(2):651-8. PubMed ID: 9449637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor.
    Beyermann M; Fechner K; Furkert J; Krause E; Bienert M
    J Med Chem; 1996 Aug; 39(17):3324-30. PubMed ID: 8765516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor (CRF) agonists with reduced amide bonds and Ser7 substitutions.
    Cervini L; Theobald P; Corrigan A; Craig AG; Rivier C; Vale W; Rivier J
    J Med Chem; 1999 Feb; 42(4):761-8. PubMed ID: 10052982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.
    Berger H; Heinrich N; Wietfeld D; Bienert M; Beyermann M
    Br J Pharmacol; 2006 Dec; 149(7):942-7. PubMed ID: 17057757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
    Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges.
    Miranda A; Lahrichi SL; Gulyas J; Koerber SC; Craig AG; Corrigan A; Rivier C; Vale W; Rivier J
    J Med Chem; 1997 Oct; 40(22):3651-8. PubMed ID: 9357532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A soluble form of the first extracellular domain of mouse type 2beta corticotropin-releasing factor receptor reveals differential ligand specificity.
    Perrin MH; DiGruccio MR; Koerber SC; Rivier JE; Kunitake KS; Bain DL; Fischer WH; Vale WW
    J Biol Chem; 2003 May; 278(18):15595-600. PubMed ID: 12611895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photoaffinity cross-linking of the corticotropin-releasing factor receptor type 1 with photoreactive urocortin analogues.
    Kraetke O; Holeran B; Berger H; Escher E; Bienert M; Beyermann M
    Biochemistry; 2005 Nov; 44(47):15569-77. PubMed ID: 16300406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor.
    Vaughan J; Donaldson C; Bittencourt J; Perrin MH; Lewis K; Sutton S; Chan R; Turnbull AV; Lovejoy D; Rivier C
    Nature; 1995 Nov; 378(6554):287-92. PubMed ID: 7477349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and relative potencies of new constrained CRF antagonists.
    Hernandez JF; Kornreich W; Rivier C; Miranda A; Yamamoto G; Andrews J; Taché Y; Vale W; Rivier J
    J Med Chem; 1993 Oct; 36(20):2860-7. PubMed ID: 8411001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single point D-substituted corticotropin-releasing factor analogues: effects on potency and physicochemical characteristics.
    Rivier J; Rivier C; Galyean R; Miranda A; Miller C; Craig AG; Yamamoto G; Brown M; Vale W
    J Med Chem; 1993 Oct; 36(20):2851-9. PubMed ID: 8411000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin releasing factor receptors and their ligand family.
    Perrin MH; Vale WW
    Ann N Y Acad Sci; 1999 Oct; 885():312-28. PubMed ID: 10816663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic screening of class-B G protein-coupled receptors.
    Devigny C; Perez-Balderas F; Hoogeland B; Cuboni S; Wachtel R; Mauch CP; Webb KJ; Deussing JM; Hausch F
    J Am Chem Soc; 2011 Jun; 133(23):8927-33. PubMed ID: 21534574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study.
    Kornreich WD; Galyean R; Hernandez JF; Craig AG; Donaldson CJ; Yamamoto G; Rivier C; Vale W; Rivier J
    J Med Chem; 1992 May; 35(10):1870-6. PubMed ID: 1316969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.
    Eckart K; Jahn O; Radulovic J; Tezval H; van Werven L; Spiess J
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11142-7. PubMed ID: 11572971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
    Myers DA; Trinh JV; Myers TR
    Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.